PLoS ONE · 2019 · 16 citations · 46 references
MedicineBiotechnologyCell BiologyCell TherapyHepatologyStem Cell BiologyHepatic FibrosisHepatic MetabolismHepatic PathologyHepatic PathophysiologyLiver DiseaseLiver RegenerationAlbumin SynthesisCholangiocyte DifferentiationGlycogen Storage In LiverHepatic DifferentiationHepatic Stem CellsHepatocyte DifferentiationHepatocyte ProliferationSelf-renewal
Direct conversion from fibroblasts to generate hepatocyte like-cells (iHeps) bypassing the pluripotent state has been described in previous reports as an attractive method acquiring hepatocytes for cell-based therapy. The limited proliferation of iHeps, however, has hampered it uses in cell-based therapy. Since hepatic stem cells (HepSCs) possess self-renewal and bipotency with the capacity to differentiate into both hepatocytes and cholangiocytes, they have therapeutic potential for treating liver disease. Here, we investigated the therapeutic effects of induced HepSCs (iHepSCs) on a carbon tetrachloride (CCl4)-induced liver fibrosis model. We demonstrate that Oct4 and Hnf4a are sufficient to convert fibroblasts into expandable iHepSCs. Hepatocyte-like cells derived from iHepSCs (iHepSC-HEPs) exhibit the typical morphology of hepatocytes and hepatic functions, including glycogen storage, low-density lipoprotein (LDL) uptake, Indocyanine green (ICG) detoxification, drug metabolism, urea production, and albumin secretion. iHepSCs-derived cholangiocyte-like cells (iHepSC-CLCs) expressed cholangiocyte-specific markers and formed cysts and tubule-like structures with apical-basal polarity and secretory function in three-dimensional culture condition. Furthermore, iHepSCs showed anti-inflammatory and anti-fibrotic effects in CCl4-induced liver fibrosis. This study demonstrates that Oct4 and Hnf4α-induced HepSCs show typical hepatic and biliary functionality in vitro. It also presents the therapeutic effect of iHepSCs in liver fibrosis. Therefore, directly converting iHepSCs from somatic cells may facilitate the development of patient-specific cell-based therapy for chronic liver damage.
46
Summaries of Affymetrix GeneChip probe level data
Rafael A. Irizarry · Nucleic Acids Research · 2003 · 5K citations · Full text
Oct4-Induced Pluripotency in Adult Neural Stem Cells
Jeong Beom Kim, Vittorio Sebastiano, Guangming Wu et al. · Cell · 2009 · 944 citations · Full text
Variation in the safety of induced pluripotent stem cell lines
Kyoko Miura, Yohei Okada, Takashi Aoi et al. · Nature Biotechnology · 2009 · 883 citations
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Pengyu Huang, Zhiying He, Shuyi Ji et al. · Nature · 2011 · 860 citations